Ing Groep NV

20-F13F13G

Institutional Holdings (13F)

See all →
NYSE
Ing Groep Nv reported 514 holdings worth $20.5B for the period ended June 30, 2026.
NYSE
ING GROEP NV has filed its quarterly Form 13F-HR report detailing its investment holdings as of March 31, 2026.
NYSE
ING Groep NV has filed its Form 13F-HR, revealing its equity holdings totaling over $16.58 billion across 553 positions as of December 31, 2025.
NYSE
ING Groep NV has filed its Form 13F-HR, revealing an institutional investment portfolio valued at over $18.48 billion across 507 equity positions as of September 30, 2025.
NYSE
ING Groep NV has filed its quarterly 13F-HR report, revealing its equity holdings totaling over $16.4 billion as of June 30, 2025.
NYSE
ING GROEP NV's latest 13F filing discloses $14.4 billion in managed securities as of March 31, 2025, showcasing a diverse portfolio of 476 holdings.

Schedule 13G - Passive Investments

NYSE
ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have reported a shared beneficial ownership of 3.99% in NEOGEN Corp's common stock.
NYSE
ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have jointly disclosed a beneficial ownership of 6.47% in NEOGEN CORP's common stock.
NYSE
Capital Research Global Investors has filed an amended Schedule 13G, reporting a beneficial ownership of 4.8% in ING Groep NV as of December 31, 2024.